JNJ-39393406

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for JNJ-39393406, covering 2012-11-08 to 2020-05-22. Get the full timeline:

Most recent: Clinical Trial Update: The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive [Phase 2]